...
首页> 外文期刊>癌と化学療法 >A case of recurrent esophageal cancer successfully treated with weekly paclitaxel in combination with radiotherapy
【24h】

A case of recurrent esophageal cancer successfully treated with weekly paclitaxel in combination with radiotherapy

机译:每周紫杉醇联合放疗成功治疗复发性食管癌一例

获取原文
获取原文并翻译 | 示例

摘要

A 48-year-old man underwent subtotal esophagectomy for pStage III (pT 3 pN 3) thoracic esophageal carcinoma on June 20, 2002, in combination with chemotherapy (5-FU 500 mg/day day 1-14, CDDP 10 mg/day day 1-14, VDS 3 mg on days 1 and 8) before and after the operation. Recurrence was seen 7 months after the operation in right pleura and lower mediastinum. Chemo (same regimen)-radiotherapy (50 Gy) was then performed but without effect. Thereafter, lung and upper mediastinal metastases were found, and weekly administration of paclitaxel (70 mg/m2, day 1, 8, 15, q 4w) was initiated in combination with radiotherapy (40 Gy). Two cycles of treatment resulted in PR, and CR was achieved after the 8th cycle was completed. Although treatment was terminated after the 12 th cycle due to development of peripheral neuropathy (grade 2), CR was still maintained 8 months after the completion of treatment. These results suggested the effectiveness of the treatment in cases that show resistance to conventional 5-FU-based chemotherapy.
机译:一名48岁的男性于2002年6月20日接受了pStage III(pT 3 pN 3)胸段食管癌大肠切除术,并联合化疗(5-FU 500 mg /天,第1-14天,CDDP 10 mg /天第1-14天,在手术前后第1天和第8天服用VDS 3 mg。术后7个月右胸膜和下纵隔复发。然后进行了化学疗法(相同的方案)放射疗法(50 Gy),但没有效果。此后,发现了肺和上纵隔转移,并开始每周一次联合放射治疗(40 Gy)给予紫杉醇(70 mg / m2,第1、8、15,q 4w天)。两个疗程导致PR,第8个疗程结束后达到CR。尽管由于周围神经病变的发展(第2级)在第12个周期后终止了治疗,但CR在治疗完成后仍保持了8个月。这些结果表明该疗法在显示出对常规基于5-FU的化学疗法耐药的病例中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号